Cell & Gene Therapy
To build and advance the supply chain of this nascent medical science to deliver affordable healthcare; to address the “Commercialization and Scaling Up of CAR-T Cell Therapy Supply Chain” through its incorporation of agility, accountability, quality and integrity in the business end-to-end.
CO-CHAIRPERSONS: Shankar Suryanarayanan, Executive Vice President, BSMA and Laura Alquist, Vice President, Supply Chain, Kite Pharma
- Dr. Alison Moore, CTO, Allogene Therapeutics
- Ron Emerey, President, Alchemy Associates
- Bernard Huyghe, Senior Director, External Supply, Allogene Therapeutics, Inc.
- Matthew Yedwabnick , Sr. Director Supply Chain , Atara Biotherapeutics
- Franck Toussaint, Managing Director, Biolog Europe
- Kenneth Locke, Global Head, Strategic Sourcing – Cell Therapies, Celgene
- Kimberly Lounds Foster, Corporate Vice President and Head of Global Commercial Supply, Celgene
- Jayant Aphale, Executive Vice President of Technical Operations, Gritstone Oncology
- Neil Ackerman, Senior Director, Enterprise Supply Chain Global Planning and Innovation, Johnson and Johnson
- Deidre Hobbs, Senior Director, Quality, Kite Pharma
- Howard Bland, Sr. Director, Sourcing & Procurement, Kite Pharma
- Marina Kreculz, Director, Category Management, Kite Pharma
- Prentice Curry, Senior Vice President, Quality, Kite Pharma
- Reggie Foster, Director Logistics and Packaging Engineering, Kite Pharma
- Tim Sirichoke, vice President, Manufacturing, Kite Pharma
- Carlo Guy, Vice President, Supply Chain, CAR-T Cell, Novartis
- Kevin Cook, Vice President Supply Chain, Novartis
- Kirstin Powell, Global Head External Quality Operations, CGTDM, Novartis
- Peter Holman, Global Apheresis Integration, Novartis
- Karen Walker, Vice President, Global Quality, Seattle Genomics
- Mandar Paralkar, Sr. Director and Digital Innovation Advisor of Life Sciences, SAP
- Jon Pieter Kapelle, Vice President of Strategy, 4G Clinical
- Kevin Cast, Partner, Archbow Consulting
- Paul Furgal, Vice President, Archbow Consulting